Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments.

MLA

Santamaria, Fiorenza, et al. “Clinical Implications of the Drug-Drug Interaction in Cancer Patients Treated with Innovative Oncological Treatments.” Critical Reviews in Oncology/Hematology, vol. 200, Aug. 2024, p. 104405. EBSCOhost, https://doi.org/10.1016/j.critrevonc.2024.104405.

APA

Santamaria, F., Roberto, M., Buccilli, D., Di Civita, M. A., Giancontieri, P., Maltese, G., Nicolella, F., Torchia, A., Scagnoli, S., Pisegna, S., Barchiesi, G., Speranza, I., Botticelli, A., & Santini, D. (2024). Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments. Critical Reviews in Oncology/Hematology, 200, 104405. https://doi.org/10.1016/j.critrevonc.2024.104405

Chicago

Santamaria, Fiorenza, Michela Roberto, Dorelsa Buccilli, Mattia Alberto Di Civita, Paola Giancontieri, Giulia Maltese, Francesco Nicolella, et al. 2024. “Clinical Implications of the Drug-Drug Interaction in Cancer Patients Treated with Innovative Oncological Treatments.” Critical Reviews in Oncology/Hematology 200 (August): 104405. doi:10.1016/j.critrevonc.2024.104405.